Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Endocr Pract. 2020 Dec 14;27(3):228–235. doi: 10.1016/j.eprac.2020.12.004

Appendix Table 1.

Patient Characteristics of Cancer Cohort and Matched Pairs

Characteristic Cancer Cohort
N = 32801 (100%)
Non-Cancer Cohort
N = 32801 (100%)
Charlson Comorbidity Score
 0 1910 (58%) 2854 (87%)
 1 829 (25%) 298 (9.1%)
 2 312 (9.5%) 79 (2.4%)
 3+ 229 (7.0%) 49 (1.5%)
Sex
 Male 672 (20%) 672 (20%)
 Female 2608 (80%) 2608 (80%)
Age at Diagnosis
71.7 (68.6, 76.1) 71.7 (68.6, 76.1)
Race
 Caucasian 2798 (85%) 2798 (85%)
 African American 182 (5.5%) 182 (5.5%)
 Other 300 (9.1%) 300 (9.1%)
Geographic Region
 West 1326 (40%) 1129 (34.4%)
 Northeast 745 (23%) 331 (10.1%)
 Midwest 376 (11%) 592 (18%)
 South 833 (25%) 534 (16.3%)
 Unknown 0 694 (21.2%)
Urban-rural Residence
 Non-Urban 500 (15%) 527 (19%)
 Urban 2780 (85%) 2289 (81%)
 Unknown 0 464
1

Statistics presented: n (%); median (IQR)